BCAT Stock Analysis: BlackRock Capital | NYSE
Asset Management | NYSE, USA | Market Cap: 1.517m USD | 12M Return: 19.5% | US09260U1097 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 10.7M
Rev. Trend: 63.9%
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 5.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
| Net Income: 222.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA -1.01 > 1.0 |
| NWC/Revenue: -93.82% < 20% (prev -100.9%; Δ 7.09% < -1%) |
| CFO/TA 0.18 > 3% & CFO 329.5m > Net Income 222.0m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 0.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.8m) vs 12m ago -1.50% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 12.18% > 50% (prev 10.59%; Δ 1.58% > 0%) |
| Interest Coverage Ratio: 155.5 > 6 (EBIT TTM 222.0m / Interest Expense TTM 1.43m) |
| A: -0.12 (Total Current Assets 7.82m - Total Current Liabilities 219.0m) / Total Assets 1.83b |
| B: 0.08 (Retained Earnings 151.8m / Total Assets 1.83b) |
| C: 0.12 (EBIT TTM 222.0m / Avg Total Assets 1.85b) |
| D: 6.23 (Book Value of Equity 1.58b / Total Liabilities 253.2m) |
| Altman-Z'' = 6.86 = AAA |
As of September 19, 2026, the stock is trading at USD 14.34 with a total of 1,285,663 shares traded. Over the past week, the price has changed by -1.40%, over one month by -7.41%, over three months by -5.02% and over the past year by +19.50%.
Current recommended Stop Loss: 13.90 (which is 3.1% or 1.5 ATR below the current price).
BlackRock Capital has no consensus analysts rating.
P/E Trailing = 5.8971
P/S = 5.9327
P/B = 0.9512
Revenue TTM = 225.0m USD
EBIT TTM = 222.0m USD
EBITDA TTM = 222.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.51b USD (1.52b + (null Debt) - CCE 7.78m)
Interest Coverage Ratio = 155.5 (Ebit TTM 222.0m / Interest Expense TTM 1.43m)
EV/FCF = 4.58x (Enterprise Value 1.51b / FCF TTM 329.5m)
FCF Yield = 21.84% (FCF TTM 329.5m / Enterprise Value 1.51b)
FCF Margin = 146.4% (FCF TTM 329.5m / Revenue TTM 225.0m)
Net Margin = 98.65% (Net Income TTM 222.0m / Revenue TTM 225.0m)
Gross Margin = unknown ((Revenue TTM 225.0m - Cost of Revenue TTM 1.43m) / Revenue TTM)
Tobins Q-Ratio = 0.82 (Enterprise Value 1.51b / Total Assets 1.83b)
Interest Expense / Debt = unknown (Interest Expense 1.43m / Debt none)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 175.4m (EBIT 222.0m * (1 - 21.00%))
Current Ratio = 0.04 (Total Current Assets 7.82m / Total Current Liabilities 219.0m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 222.0m)
Debt / FCF = unknown (Net Debt none / FCF TTM 329.5m)
Total Stockholder Equity = 1.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.01% (Net Income 222.0m / Total Assets 1.83b)
RoE = 13.59% (Net Income TTM 222.0m / Total Stockholder Equity 1.63b)
RoCE = 13.78% (EBIT 222.0m / Capital Employed (Total Assets 1.83b - Current Liab 219.0m))
RoIC = 10.94% (NOPAT 175.4m / Invested Capital 1.60b)
WACC = 8.37% (E(1.52b)/V(1.52b) * Re(8.37%) + (debt-free company))
Discount Rate = 8.37% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.96 | Cagr: -2.34%
[DCF] Terminal Value 74.34% ; FCFF base≈339.7m ; Y1≈320.6m ; Y5≈300.1m
[DCF] Fair Price = 44.56 (EV 4.72b - Net Debt 0.0 = Equity 4.72b / Shares 105.8m; r=8.37% [WACC]; 5y FCF grow -7.15% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 63.87 | Revenue CAGR: 4.29% | SUE: N/A | # QB: 0